I propose a slight change to the order of the agenda by going on to consider PE1651, by Marion Brown on behalf of Recovery and Renewal, on prescribed drug dependence and withdrawal. I welcome to the meeting Jackie Baillie MSP, who has an interest in this petition. I will allow her to participate and then we can go back and deal with the two petitions that we have moved away from.
Members might wish to note that some new written submissions have recently been received on this petition. They will be brought to our attention once they have been checked by the clerks to ensure that they comply with the Parliament’s policy on submitting written evidence.
At our previous consideration of this petition, we agreed to write to the Scottish Government to ask what engagement it had had with Public Health England on its review of the evidence for dependence on and withdrawal from prescribed medicines. The Government explains that it wrote to Public Health England to ask it to consider extending the scope of the review to include Scotland, but it responded by stating that, although it was happy to share the review’s outcomes, it had no plans to extend it. The Government’s response also states that it is currently exploring the possibility of taking forward a Scotland-focused review, which would run in parallel with the Public Health England review.
The committee will recall that it also agreed to write to the British Medical Association to ask about its current position on the roll-out of a national 24-hour helpline, recognising that it had been over two years since the organisation had made that policy call. The response indicates that although the BMA continues to support the call, the establishment of a helpline
“should be clearly understood as a supplement to ongoing care from prescribers, not a replacement.”
The committee also wrote to the Royal College of General Practitioners and the British Medical Association’s Scottish GP committee to establish the extent to which GPs in Scotland recognise the issues raised in the petition and to find out what guidance and training was available to GPs to support people in withdrawing safely from drugs such as benzodiazepines and anti-depressants. Responses have been received and are included in our meeting papers.
In her most recent written submission, the petitioner draws our attention to the UK Parliament’s all-party parliamentary group on prescribed drug dependence, which has published a report based on an analysis of personal accounts of prescribed drug dependence and withdrawal submitted in petitions in Scotland and Wales. The petitioner wishes to draw particular attention to the patient journey maps that are featured in this report and which for ease of reference have been printed out and placed on our desks for review at today’s meeting.
I also think it worth while to comment on the very substantial number of submissions that we have received from individuals. Having read them all in detail, I can say that I have found them very interesting and thought provoking, and I want to thank the people who have taken the time to respond. It should also be noted that the submissions contain responses from GPs and people from the medical profession as well as people who have identified concerns as a result of their own experience of prescribed drug dependence.
Do members have any comments or suggestions for action on an issue that has clearly generated a degree of interest that goes broader than the committee? I do not know whether it would be worth asking Jackie Baillie for her views. Ms Baillie, I think that one of the petitioners is a constituent of yours, and you might want to inform our thinking with your comments.

